TATA Health International Holdings Limited provided earnings guidance for the year ended December 31, 2020. For the year, the group expects to record a net loss attributable to the parent company in the range of approximately HKD 150 million to approximately HKD 170 million. The expected net loss for the Year was mainly attributable to (i) the footwear and healthcare businesses, which constitute the main sources of revenue for the Group, being severely affected by the continuous decline in the number of visitors to Hong Kong caused by the COVID-19 pandemic and the consumers being more prudent during the global economic downturn. It is expected that the overall sales revenue of the Group for the Year will decrease by approximately 50%­60% as compared to the corresponding period in the previous year; and (ii) an increased impairment loss of assets will be recorded for the Year, including but not limited to the allowance for inventories of footwear products, right-of-use assets and intangible assets.